Skip to content

RoosterBio

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • High Volume hMSCs
      • XF hBM-MSCs
      • XF hUC-MSCs
      • XF RTP hBM-MSCs
      • Traditional hBM-MSCs
      • Traditional RTP hBM-MSCs
    • hMSC Bioprocess Media
      • XF hMSC Bioprocess Media
      • XF hMSC Bioreactor Feeds
      • XF hMSC Bioprocess Supplements & Reagents
      • Traditional hMSC Bioprocess Media
    • CliniControl Products
      • CliniControl High Volume hMSCs
      • CliniControl hMSC Bioprocess Media
      • CliniControl Extracellular Vesicle (EV) Production
    • Extracellular Vesicle (EV) Production
      • EV Collection Media
      • EV Supplements & Reagents
    • hMSC Kits
      • RoosterVial & RoosterNourish Test Kits
      • Donor Screening Test Kits
      • Bioreactor Starter Kits
      • Bioreactor Development Kits
      • Bioprinting Kits
      • Bioprinting RTP Kits
  • Services
    • Process Development Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Search Publications

Therapeutic Indication

Tech Segment

Reset
Characterising the Phenotypic Evolution of Circulating Tumour Cells During Treatment
April 2018 Cancer, Cell Therapy, Drug Screening

Characterising the Phenotypic Evolution of Circulating Tumour Cells During Treatment

Deciphering the Role of Substrate Stiffness in Enhancing the Internalization Efficiency of Plasmid DNA in Stem Cells Using Lipid-based Nanocarriers
May 2018 Cardiovascular, Gene Editing

Deciphering the Role of Substrate Stiffness in Enhancing the Internalization Efficiency of Plasmid DNA in Stem Cells Using Lipid-based Nanocarriers

Impact of Vancomycin Treatment on Human Mesenchymal Stromal Cells During Osteogenic Differentiation
April 2018 Drug Screening, Orthopedic

Impact of Vancomycin Treatment on Human Mesenchymal Stromal Cells During Osteogenic Differentiation

Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities
August 2018 Cardiovascular, MedTech, Devices, & Materials, Tissue & Organ Engineering

Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities

Mesenchymal Stem Cell-derived Extracellular Vesicles Attenuate Pulmonary Vascular Permeability and Lung Injury Induced by Hemorrhagic Shock and Trauma
February 2018 Cell Therapy, EVs & MSC Secretome, Pulmonary

Mesenchymal Stem Cell-derived Extracellular Vesicles Attenuate Pulmonary Vascular Permeability and Lung Injury Induced by Hemorrhagic Shock and Trauma

Bioprocess Integration for Human Mesenchymal Stem Cells: From Up to Downstream Processing Scale-up to Cell Proteome Characterization
February 2017 Bioprocess Tool Development

Bioprocess Integration for Human Mesenchymal Stem Cells: From Up to Downstream Processing Scale-up to Cell Proteome Characterization

Substrate Stress-Relaxation Regulates Scaffold Remodeling and Bone Formation In Vivo
December 2016 Cell Therapy, Orthopedic, Tissue & Organ Engineering

Substrate Stress-Relaxation Regulates Scaffold Remodeling and Bone Formation In Vivo

Biodegradable Poly-ε-caprolactone Microcarriers for Efficient Production of Human Mesenchymal Stromal Cells and Secreted Cytokines in Batch and Fed-batch Bioreactors
December 2016 Bioprocess Tool Development

Biodegradable Poly-ε-caprolactone Microcarriers for Efficient Production of Human Mesenchymal Stromal Cells and Secreted Cytokines in Batch and Fed-batch Bioreactors

In Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs
February 2017 Bioprinting, Orthopedic, Tissue & Organ Engineering

In Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
May 2018 Cancer, Cell Therapy, Drug Screening

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer

Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next

Careers

Contact Us

Contact Information

RoosterBio, Inc.
Email: info@roosterbio.com Phone: +1 301-200-5366

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Email

Copyright © 2021 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.